Table 3.
Study 3 sample demographics at screen
| PPI Users (n=21) | PPI Non-users (n=121) | ||||
|---|---|---|---|---|---|
| Measure | N (%) | M (SD) | N (%) | M (SD) | |
| Age | 55.7(9.1) | 55.6(7.7) | |||
| Comorbidities | 0.3(0.6) | 0.2(0.5) | |||
| Months since cancer tx | 53.1(19.9) | 43.0(27.7) | |||
| Race (% White) | 20(95%) | 106(88%) | |||
| Education | High School | 6(29%) | 16(13%) | ||
| Some College | 2(10%) | 25(21%) | |||
| College Grad | 6(29%) | 37(31%) | |||
| Grad Training | 7(33%) | 43(34%) | |||
| Chemo tx (% Yes) | 16(80%) | 88(73%) | |||
| Hormone tx (% Yes) | 14(65%) | 95(79%) | |||
| Radiation tx (% Yes) | 9(43%) | 68(56%) | |||
| CES-D score | 9.1(8.0) | 7.1(7.3) | |||
| Cancer Stage | Stage I | 6(29%) | 50(41%) | ||
| Stage II | 11(52%) | 63(52%) | |||
| Stage III | 1(5%) | 8(7%) | |||
p<0.05